Stempoint Capital »

Erasca shares owned by Stempoint Capital

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.9M 240k 16.18

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Praxis Precision Medicines I Com New (PRAX)
Surrozen Com New (SRZN)
Mbx Biosciences (MBX)
Mbx Biosciences (MBX)
Mineralys Therapeutics (MLYS)
Mineralys Therapeutics (MLYS)
Enliven Therapeutics (ELVN)
Enliven Therapeutics (ELVN)
Cg Oncology (CGON)
Cg Oncology (CGON)
Biohaven (BHVN)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Erasca

Frazier Life Sciences Management
BlackRock
VR Adviser
T. Rowe Price Investment Management
Vanguard Group
Vivo Capital
Vanguard Capital Management
Logos Global Management
Paradigm Biocapital Advisors
Siren
Arch Venture Corp
State Street Corporation
Geode Capital Management
Cormorant Asset Management
Balyasny Asset Management

View all funds holding Erasca